188824-65-9

Upstream product

• 106-41-2 4-bromo-phenol 
• 2008-75-5 N-chloroethylpiperidine hydrochloride 
• 836-58-8 1-[2-(4-bromophenoxy)ethyl]piperidine 

Downstream Products

• 84541-38-8 [6-Methoxy-2-(4-Methoxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-Piperidinyl)ethoxy]phenyl] Methanone 
• 188824-03-5 Trifluoro-methanesulfonic acid 6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-trifluoromethanesulfonyloxy-6H-5-oxa-11-thia-benzo[a]fluoren-9-yl ester 
• 188823-98-5 raloxifene 
• 188824-32-0 1-(2-{4-[3,9-Bis-(tert-butyl-dimethyl-silanyloxy)-6H-5-oxa-11-thia-benzo[a]fluoren-6-yl]-phenoxy}-ethyl)-piperidine 
• 188824-45-5 1-(2-{4-[9-(tert-Butyl-dimethyl-silanyloxy)-6H-5-oxa-11-thia-benzo[a]fluoren-6-yl]-phenoxy}-ethyl)-piperidine 
• 188824-57-9 1-(2-{4-[3,9-Bis-(tert-butyl-dimethyl-silanyloxy)-6H-benzo[4,5]furo[3,2-c]chromen-6-yl]-phenoxy}-ethyl)-piperidine 

Relevant academic research and scientific papers

Novel process and intermediates for preparing 17-halogenated 19-norsteroid compounds

The invention relates to a process for preparing compounds of formula (I): in which R1, R2, R3, n and X are as defined in the description, and to the intermediate compounds for implementing this process.

2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

2H-1-benzopyran derivatives, processes for their preparation and use thereof for the preparation of pharmaceutical compositions for the prevention and treatment of postmenopausal pathologies.